PremiumThe FlyAlzamend Neuro announces initiation data of Phase II trial of AL001 Alzamend Neuro announces completion of head coil by Tesla Dynamic Coils Alzamend Neuro says net cash gained by financing activity $8.3M PremiumThe FlyAlzamend Neuro executed deal to provide sufficient capital for 18 months Alzamend Neuro teams with MGH for lithium drug AL001 trial to treat PTSD Alzamend Neuro teams with Mass General for trial of AL001 for MDD PremiumThe FlyAlzamend Neuro trading halted, news pending Alzamend Neuro Announces Reverse Stock Split Decision Alzamend Neuro announces one-for-ten reverse stock split 
